Daiichinkyo CoDSKYF -4.91%73 OCF Margin % is 4.39% as of Mar. 2026, which is 64% below its 10-year median of 12.31. GuruFocus rates DSKYF with a GF Score™ of 73/100 and a GF Value™ of $40.31 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 959 Drug Manufacturers companies, Daiichinkyo Co ranks worse than 64.44% on this metric.
The historical rank and industry rank for Daiichinkyo Co's OCF Margin % or its related term are showing as below:
DSKYF'
s OCF Margin % Range Over the Past 10 Years
Min: 2.85 Med: 12.31 Max: 37.41
Current: 3.43
During the past 13 years, the highest OCF Margin % of Daiichinkyo Co was 37.41%. The lowest was 2.85%. And the median was 12.31%.
DSKYF's OCF Margin % is ranked worse than 64.44% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs DSKYF: 3.43
Daiichinkyo Co OCF Margin % Related Terms
Daiichinkyo Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Daiichinkyo Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Daiichinkyo Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiichinkyo Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Daiichinkyo Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiichinkyo Co (DSKYF) has a OCF Margin % of 4.39% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Daiichinkyo Co and its competitors. This is 64% below median its historical median of 12.31. Over the past decade, Daiichinkyo Co's OCF Margin % has ranged from 2.85 to 37.41. According to the industry distribution chart, Daiichinkyo Co ranks #618 out of 959 companies in the Drug Manufacturers industry, placing it in the top 64.4%.
Is Daiichinkyo Co's OCF Margin % too high?
Daiichinkyo Co's current OCF Margin % of 4.39% is 64% below median its 10-year median of 12.31. Over the past 10 years, this metric has ranged from a low of 2.85 to a high of 37.41. The Drug Manufacturers industry median OCF Margin % is 9.95. Daiichinkyo Co's value of 4.39% is 55.9% below this industry median. Based on the distribution chart, Daiichinkyo Co ranks #618 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Daiichinkyo Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #618 out of 959 companies for OCF Margin %. This places Daiichinkyo Co in the lower half of its industry. The industry median OCF Margin % is 9.95. Daiichinkyo Co's value of 4.39% is 55.9% below this benchmark. Historically, Daiichinkyo Co's own OCF Margin % has ranged from 2.85 to 37.41 over the past decade. While the company's 10-year median is 12.31 vs. the industry median of 9.95, Daiichinkyo Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiichinkyo Co's current OCF Margin % of 4.39% is 55.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Daiichinkyo Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiichinkyo Co's current OCF Margin % is 4.39%, which is 64% below median its own 10-year median of 12.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSKYF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.31, compared to a current price of $14.76 — trading 63.4% below its estimated fair value. The current OCF Margin % is 4.39%, which is 64% below median its 10-year median of 12.31 and 55.9% below the Drug Manufacturers industry median of 9.95. Daiichinkyo Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Daiichinkyo Co (DSKYF), the current OCF Margin % is 4.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiichinkyo Co (DSKYF) Overvalued in 2026?
Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued.
The current stock price of $14.76 is trading 63.4% below its estimated GF Value™ of $40.31.
GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.
Key valuation signals for DSKYF:
OCF Margin %: 4.39% (64% below median its 10-year median of 12.31)
GF Value™: $40.31 vs. price of $14.76 (63.4% below fair value)
Industry Position: 55.9% below the Drug Manufacturers median (#618 of 959)
No single metric tells the full story. See the DSKYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
73GF Score
Get the complete analysis for DSKYF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSKYF has been successfully added to your 
